Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension

REFERENCES

• Dhungana S, Sharrack B, Woodroofe N. Idiopathic intracranial hypertension. Acta Neurol Scand 2010;121:71–82
   PubMed Web of Science ®Google Scholar
• Raoof N, Sharrack B, Pepper IM, Hickman SJ. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 2011;18:1266–1268
   PubMed Web of Science ®Google Scholar
• Best J, Silvestri G, Burton B, Foot B, Acheson J. The incidence of blindness due to idiopathic intracranial hypertension in the UK. Open Ophthalmol J 2013;7:26–29
   PubMedGoogle Scholar
• Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2005;3:CD003434
   Google Scholar
• The NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss. JAMA 2014;311:1641–1651
   Google Scholar
• Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, Jacks A, Lawden M, Clarke CE, Stewart PM, Walker EA, Tomlinson JW, Rauz S. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ 2010;341:c2701
   PubMed Web of Science ®Google Scholar
• National Task Force on the Prevention and Treatment of Obesity. Very low-calorie diets. JAMA 1993;270:967–974
   Web of Science ®Google Scholar
• Pineles SL, Volpe NJ. Long-term results of optic nerve sheath fenestration for idiopathic intracranial hypertension: earlier intervention favours improved outcomes. Neuro-Ophthalmology 2013;37:12–19
   Web of Science ®Google Scholar
• Ahmed RM, Wilkinson M, Parker GD, Thurtell MJ, Macdonald J, McCluskey PJ, Allan R, Dunne V, Hanlon M, Owler BK, Halmagyi GM. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol 2011;32:1408–1414
   PubMed Web of Science ®Google Scholar
• Rosenberg ML, Corbett JJ, Smith C, Goodwin J, Sergott R, Savino P, Schatz N. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993;43:1071–1072
   PubMed Web of Science ®Google Scholar
• Maher CO, Garrity JA, Meyer FB. Refractory idiopathic intracranial hypertension treated with stereotactically planned ventriculoperitoneal shunt placement. Neurosurg Focus 2001;10:1–4
   PubMedGoogle Scholar
• Curry WT, Butler WE, Barker FG. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988–2002. Neurosurgery 2005;57:97–108
   PubMed Web of Science ®Google Scholar
• Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492–1495
   PubMed Web of Science ®Google Scholar
• Newman WD, Tocher K, Acheson JF. Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal. Eye (Lond) 2002;16:567–571
   Google Scholar
• Hickman SJ. Neuro-ophthalmology. Pract Neurol 2011;11:191–200
   Google Scholar
• Julious SA. Sample sizes for clinical trials with Normal data. Stat Med 2004;23:1921–1986
   PubMed Web of Science ®Google Scholar
• Lange S, Freitag G. Choice of delta: requirements and reality—results of a systematic review. Biom J 2005;47:12–27
   PubMed Web of Science ®Google Scholar
• Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996;46:1524–1530
   PubMed Web of Science ®Google Scholar
• Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997;49:734–739
   PubMed Web of Science ®Google Scholar
• Bynke G, Zemack G, Bynke H, Romner B. Ventriculoperitoneal shunting for idiopathic intracranial hypertension. Neurology 2004;63:1314–1316
   PubMed Web of Science ®Google Scholar
• McGirt MJ, Woodworth G, Thomas G, Miller N, Williams M, Rigamonti D. Cerebrospinal fluid shunt placement for pseudotumor cerebri-associated intractable headache: predictors of treatment response and an analysis of long-term outcomes. J Neurosurg 2004;101:627–632
   PubMed Web of Science ®Google Scholar
• Abu-Serieh B, Ghassempour K, Duprez T, Raftopoulos C. Stereotactic ventriculoperitoneal shunting for refractory idiopathic intracranial hypertension. Neurosurgery 2007;60:1039–1044
   PubMed Web of Science ®Google Scholar
• Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O'Brien D. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts—case series and literature review. Br J Neurosurg 2011;25:94–99
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia 2011;31:1627–1633
   PubMed Web of Science ®Google Scholar
• Tarnaris A, Toma AK, Watkins LD, Kitchen ND. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site: a single centre experience. Clin Neurol Neurosurg 2011;113:477–479
   PubMed Web of Science ®Google Scholar
• Yadav YR, Parihar V, Agarwal M, Bhatele PR, Saxena N. Lumbar peritoneal shunt in idiopathic intracranial hypertension. Turk Neurosurg 2010;22:21–26
   Google Scholar
• Huang LC, Winter TW, Herro AM, Rosa PR, Schiffman JC, Pasol J, Trombly RS, Tawfik M, Lam BL. Ventriculoperitoneal shunt as a treatment of visual loss in idiopathic intracranial hypertension. J Neuroophthalmol 2014;34: 223–228
   PubMed Web of Science ®Google Scholar
• Spitze A, Malik A, Al-Zubidi N, Golnik K, Lee AG. Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy? J Neuroophthalmol 2013;33:183–188
   Google Scholar
• Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol 2011;31:374–380
   Google Scholar
• Feldon SE. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus 2007;23:E6
   Google Scholar
• Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJW, CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152–1160
   PubMed Web of Science ®Google Scholar
• van der Graaf R, van Delden JJ. On what we will lose in giving up on clinical equipoise: a reply to Miller. Clin Trials 2012;9:628–629
   Google Scholar
• Nowomiejska K, Vonthein R, Paetzold J, Zagorski Z, Kardon R, Schiefer U. Comparison between semiautomated kinetic perimetry and conventional Goldmann manual kinetic perimetry in advanced visual field loss. Ophthalmology 2005;112:1343–1354
   PubMed Web of Science ®Google Scholar
• Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155–180
   PubMed Web of Science ®Google Scholar